UniProt ID | XPO1_MOUSE | |
---|---|---|
UniProt AC | Q6P5F9 | |
Protein Name | Exportin-1 | |
Gene Name | Xpo1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 1071 | |
Subcellular Localization | Cytoplasm. Nucleus, nucleoplasm. Nucleus, Cajal body. Nucleus, nucleolus. Located in the nucleoplasm, Cajal bodies and nucleoli. Shuttles between the nucleus/nucleolus and the cytoplasm (By similarity).. | |
Protein Description | Mediates the nuclear export of cellular proteins (cargos) bearing a leucine-rich nuclear export signal (NES) and of RNAs. In the nucleus, in association with RANBP3, binds cooperatively to the NES on its target protein and to the GTPase Ran in its active GTP-bound form. Docking of this complex to the nuclear pore complex (NPC) is mediated through binding to nucleoporins. Upon transit of a nuclear export complex into the cytoplasm, disassembling of the complex and hydrolysis of Ran-GTP to Ran-GDP (induced by RANBP1 and RANGAP1, respectively) cause release of the cargo from the export receptor. The directionality of nuclear export is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. Involved in U3 snoRNA transport from Cajal bodies to nucleoli. Binds to late precursor U3 snoRNA bearing a TMG cap (By similarity).. | |
Protein Sequence | MPAIMTMLADHAARQLLDFSQKLDINLLDNVVNCLYHGEGAQQRMAQEVLTHLKEHPDAWTRVDTILEFSQNMNTKYYGLQILENVIKTRWKILPRNQCEGIKKYVVGLIIKTSSDPTCVEKEKVYIGKLNMILVQILKQEWPKHWPTFISDIVGASRTSESLCQNNMVILKLLSEEVFDFSSGQITQVKAKHLKDSMCNEFSQIFQLCQFVMENSQNAPLVHATLETLLRFLNWIPLGYIFETKLISTLIYKFLNVPMFRNVSLKCLTEIAGVSVSQYEEQFETLFTLTMMQLKQMLPLNTNIRLAYSNGKDDEQNFIQNLSLFLCTFLKEHGQLLEKRLNLREALMEALHYMLLVSEVEETEIFKICLEYWNHLAAELYRESPFSTSASPLLSGSQHFDIPPRRQLYLTVLSKVRLLMVSRMAKPEEVLVVENDQGEVVREFMKDTDSINLYKNMRETLVYLTHLDYVDTEIIMTKKLQNQVNGTEWSWKNLNTLCWAIGSISGAMHEEDEKRFLVTVIKDLLGLCEQKRGKDNKAIIASNIMYIVGQYPRFLRAHWKFLKTVVNKLFEFMHETHDGVQDMACDTFIKIAQKCRRHFVQVQVGEVMPFIDEILNNINTIICDLQPQQVHTFYEAVGYMIGAQTDQTVQEHLIEKYMLLPNQVWDSIIQQATKNVDILKDPETVKQLGSILKTNVRACKAVGHPFVIQLGRIYLDMLNVYKCLSENISAAIQANGEMVTKQPLIRSMRTVKRETLKLISGWVSRSNDPQMVAENFVPPLLDAVLIDYQRNVPAAREPEVLSTMAIIVNKLGGHITAEIPQIFDAVFECTLNMINKDFEEYPEHRTNFFLLLQAVNSHCFPAFLAIPPAQFKLVLDSIIWAFKHTMRNVADTGLQILFTLLQNVAQEEAAAQSFYQTYFCDILQHIFSVVTDTSHTAGLTMHASILAYMFNLVEEGKISTPLNPGNPVNNQMFIQDYVANLLKSAFPHLQDAQVKLFVTGLFSLNQDIPAFKEHLRDFLVQIKEFAGEDTSDLFLEERETALRQAQEEKHKLQMSVPGILNPHEIPEEMCD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
34 | Glutathionylation | LLDNVVNCLYHGEGA HHHHHHHHHHCCCHH | 2.42 | 24333276 | |
164 | S-nitrosylation | SRTSESLCQNNMVIL CCCCHHHHHCCCHHH | 5.91 | 24926564 | |
323 | Phosphorylation | QNFIQNLSLFLCTFL HHHHHHHHHHHHHHH | 25.32 | 21454597 | |
384 | Phosphorylation | AAELYRESPFSTSAS HHHHHHHCCCCCCCC | 23.42 | 29472430 | |
387 | Phosphorylation | LYRESPFSTSASPLL HHHHCCCCCCCCCCC | 25.49 | 21149613 | |
388 | Phosphorylation | YRESPFSTSASPLLS HHHCCCCCCCCCCCC | 28.79 | 21149613 | |
389 | Phosphorylation | RESPFSTSASPLLSG HHCCCCCCCCCCCCC | 26.08 | 21149613 | |
391 | Phosphorylation | SPFSTSASPLLSGSQ CCCCCCCCCCCCCCC | 18.82 | 21149613 | |
395 | Phosphorylation | TSASPLLSGSQHFDI CCCCCCCCCCCCCCC | 44.04 | 21149613 | |
397 | Phosphorylation | ASPLLSGSQHFDIPP CCCCCCCCCCCCCCC | 19.67 | 25777480 | |
446 | Acetylation | EVVREFMKDTDSINL HHHHHHHCCCCCCCH | 63.90 | 23806337 | |
448 | Phosphorylation | VREFMKDTDSINLYK HHHHHCCCCCCCHHH | 26.57 | - | |
450 | Phosphorylation | EFMKDTDSINLYKNM HHHCCCCCCCHHHHH | 18.57 | 28066266 | |
454 | Phosphorylation | DTDSINLYKNMRETL CCCCCCHHHHHHHHH | 8.88 | - | |
455 | Acetylation | TDSINLYKNMRETLV CCCCCHHHHHHHHHH | 47.65 | 23236377 | |
455 | Ubiquitination | TDSINLYKNMRETLV CCCCCHHHHHHHHHH | 47.65 | - | |
455 | Malonylation | TDSINLYKNMRETLV CCCCCHHHHHHHHHH | 47.65 | 26320211 | |
514 | Acetylation | AMHEEDEKRFLVTVI CCCHHHHHHHHHHHH | 61.85 | 30985939 | |
531 | Ubiquitination | LLGLCEQKRGKDNKA HHHHHHHHCCCCCCE | 40.60 | - | |
563 | Acetylation | RAHWKFLKTVVNKLF HHHHHHHHHHHHHHH | 42.26 | 22826441 | |
686 | Acetylation | LKDPETVKQLGSILK CCCHHHHHHHHHHHH | 47.42 | 23236377 | |
693 | Ubiquitination | KQLGSILKTNVRACK HHHHHHHHHCHHHHH | 36.06 | - | |
693 | Acetylation | KQLGSILKTNVRACK HHHHHHHHHCHHHHH | 36.06 | 23954790 | |
700 | Ubiquitination | KTNVRACKAVGHPFV HHCHHHHHHHCCCHH | 45.16 | - | |
700 | Malonylation | KTNVRACKAVGHPFV HHCHHHHHHHCCCHH | 45.16 | 26320211 | |
764 | Phosphorylation | KLISGWVSRSNDPQM HHHHHHHHCCCCHHH | 24.39 | 22817900 | |
1030 | Phosphorylation | KEFAGEDTSDLFLEE HHHCCCCCHHHHHHH | 21.60 | 28066266 | |
1031 | Phosphorylation | EFAGEDTSDLFLEER HHCCCCCHHHHHHHH | 44.64 | 28066266 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of XPO1_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of XPO1_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of XPO1_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
FABPH_HUMAN | FABP3 | physical | 20360068 | |
XPO1_HUMAN | XPO1 | physical | 20360068 | |
XDH_HUMAN | XDH | physical | 20360068 | |
TZAP_HUMAN | ZBTB48 | physical | 26496610 | |
NUP98_HUMAN | NUP98 | physical | 26496610 | |
CCNK_HUMAN | CCNK | physical | 26496610 | |
PRP4B_HUMAN | PRPF4B | physical | 26496610 | |
GANAB_HUMAN | GANAB | physical | 26496610 | |
SCNM1_HUMAN | SCNM1 | physical | 26496610 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...